Oxygentherapy: Background and Indications
In more than 30 years of research work, Dr.med. H. S. Regelsberger developed the administration of medical oxygen into a safe and practical therapy method with few side effects.
Dr. med. H.S.: Regelsberger called the slow and precisely dosed (1-2 ml/min) intravenous administration of medical oxygen as oxyvenation.
The approximately 8-fold-increased formation of the hormone prostacyclin (the major thrombocyte aggregation inhibitor), which stimulates blood circulation, causes vessels in the entire body to dilate.
This is the conclusion to which Hanover Medical School’s Institute for Clinical Pharmacology (Prof. J.C. Frölich) came.
A similar mechanism of action develops due to “eosinophilia”:
The eosinophiliac granulocytes are able to form a substance which blocks the leukotriene synthesis from the arachidonic acid cascade.
This leads to a strong anti-inflammatory effect. The tumour necrosis factor 1 α on average decreases by 50-70% (work by Prof. Kühn at Charité Berlin)
Considerations about oxygentherapy
Subjective and general effects:
- Measurable increase in walking distance
- Regulation of cardiovascular diseases
- Quick mobilisation of edemas
- Anti-inflammatory effect
- Improved duration and depth of sleep
- Significantly better mood
- Stronger resistance to infections
Objective effects can be confirmed by:
o Ultrasound doppler pressure measurement
o Blood analysis (e.g. improved liver and kidney values)
o Blood pressure measurement
o Improved visus values (in particular in case of macula degeneration, clinical trial)
o Blood gas analysis and treadmill ergometry
Considerations about oxyvenation
Therapeutical effects of oxyvenation:
- Treatment for insomnia
- Slight increase of body temperature
- Stabilization of Blood pH
- Enhancing of immune system by increasing white cells
- Decrease of blood density
- Decrease of conventional medication
- Increase of patient’s physical conditions
- Improvement of the levels of hemoglobin, uric and lactic acid, lipoproteins, cholesterol and triglycerides and transaminases
- Risk reduction of thrombosis by increasing fibrinogens
- Improvement of respiratory functions
- Circulatory problems: venous, arterial, edema, ulcers and gangrene
- Decrease of cerebral circulation: post- apoplectic state
- Heart weaknesses
- As pre-operative measures
- Bronchial asthma, rhinoconjunctivitis, allergic dermatitis
- Brain spasms of any etiology, perivenous encephalitis, cerebral insufficiency and mental retardation
- Dysmenorrhea, chronic nephritis, hypertension, renal failure, dialysis patients
- Balance problems, glaucoma, circulatory problems in vision, pigmental retinitis
Contraindications: all severe illnesses and after brain trauma accidents, open wounds, severe asthma, and after three months of episodes of myocardial infarction.